ReCode Therapeutics Funding & Investors
ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases.
recodetx.comTotal Amount Raised: $521,799,392
ReCode Therapeutics Funding Rounds
Series Unknown
$10,000,000
Series Unknown Investors
Cystic Fibrosis FoundationSeries B
$120,000,000
Series B Investors
Matrix Capital ManagementPfizer Venture InvestmentsSanofi VenturesLeaps by BayerAmgen VenturesSeries B
$259,799,396
Series B Investors
Colt VenturesSuperstring CapitalEcoR1 CapitalTekla Capital ManagementHunt Technology VenturesVida VenturesOsage University PartnersMPM CapitalPfizer Venture InvestmentsNS InvestmentSanofi VenturesOrbiMed AdvisorsSeries A
$80,000,000
Series A Investors
Colt VenturesHunt Technology VenturesVida VenturesOsage University PartnersMPM CapitalOrbiMed AdvisorsSeries B
$50,000,000
Series B Investors
EcoR1 CapitalVida VenturesMatrix Capital ManagementOsage University PartnersMPM CapitalSolasta VenturesPfizer Venture InvestmentsSanofi VenturesLeaps by BayerOrbiMed AdvisorsAmgen VenturesBioluminescence VenturesSeed
$2,000,000
Funding info provided by Diffbot.